Moderna (MRNA) Tops Q1 EPS by 194c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/4/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- Tanker struck by projectile in Strait of Hormuz
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- AppLovin shares fall after court denies request against Unity
Moderna (MRNA) Q1 earnings, revenue surprisingly tops consensus estimates
May 4, 2023 9:50 AM EDTModerna (NASDAQ: MRNA) shares opened higher Thursday on the back of its surprising earnings and revenue beat.
The drugmaker had been expected to post a $1.75 loss in the quarter, however, it reported Q1 EPS of $0.19, topping expectations by $1.94. In addition, revenue... More
